| Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial S Paramsothy, MA Kamm, NO Kaakoush, AJ Walsh, J van den Bogaerde, ... The Lancet 389 (10075), 1218-1228, 2017 | 1179 | 2017 |
| Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis S Paramsothy, S Nielsen, MA Kamm, NP Deshpande, JJ Faith, ... Gastroenterology 156 (5), 1440-1454. e2, 2019 | 381 | 2019 |
| Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection M Julsgaard, LA Christensen, PR Gibson, RB Gearry, J Fallingborg, ... Gastroenterology 151 (1), 110-119, 2016 | 348 | 2016 |
| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 269 | 2017 |
| HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants GA Heap, MN Weedon, CM Bewshea, A Singh, M Chen, JB Satchwell, ... Nature genetics 46 (10), 1131-1134, 2014 | 210 | 2014 |
| Anemia and iron deficiency in gastrointestinal and liver conditions J Stein, S Connor, G Virgin, DEH Ong, L Pereyra World journal of gastroenterology 22 (35), 7908, 2016 | 179 | 2016 |
| Donor recruitment for fecal microbiota transplantation S Paramsothy, TJ Borody, E Lin, S Finlayson, AJ Walsh, D Samuel, ... Inflammatory bowel diseases 21 (7), 1600-1606, 2015 | 166 | 2015 |
| CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn’s disease SJ Connor, N Paraskevopoulos, R Newman, N Cuan, T Hampartzoumian, ... Gut 53 (9), 1287-1294, 2004 | 113 | 2004 |
| Improved survival in young women with colorectal cancer JH Koo, B Jalaludin, SKC Wong, A Kneebone, SJ Connor, RWL Leong Official journal of the American College of Gastroenterology| ACG 103 (6 …, 2008 | 99 | 2008 |
| Inflammatory bowel disease environmental risk factors: a population-based case–control study of Middle Eastern migration to Australia Y Ko, V Kariyawasam, M Karnib, R Butcher, D Samuel, A Alrubaie, ... Clinical Gastroenterology and Hepatology 13 (8), 1453-1463. e1, 2015 | 86 | 2015 |
| Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population JH Koo, MM Arasaratnam, K Liu, DM Redmond, SJ Connor, JJY Sung, ... Cancer Epidemiology 34 (5), 604-610, 2010 | 77 | 2010 |
| acute severe ulcerative colitis–evidence‐based consensus statements JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ... Alimentary pharmacology & therapeutics 44 (2), 127-144, 2016 | 73 | 2016 |
| Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice C Haifer, CR Kelly, S Paramsothy, D Andresen, LE Papanicolas, ... Gut 69 (5), 801-810, 2020 | 70 | 2020 |
| Efficacy of rectal tacrolimus for induction therapy in patients with resistant ulcerative proctitis IC Lawrance, A Baird, D Lightower, G Radford-Smith, JM Andrews, ... Clinical Gastroenterology and Hepatology 15 (8), 1248-1255, 2017 | 61 | 2017 |
| Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease AJ Walsh, M Weltman, D Burger, S Vivekanandarajah, S Connor, ... Journal of Crohn's and Colitis 7 (10), e449-e456, 2013 | 54 | 2013 |
| Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors MC Grimm, R Newman, Z Hassim, N Cuan, SJ Connor, Y Le, JM Wang, ... The Journal of Immunology 171 (10), 4990-4994, 2003 | 54 | 2003 |
| Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse V Aggarwal, AS Day, S Connor, ST Leach, G Brown, R Singh, A Friedman, ... Gastrointestinal endoscopy 86 (6), 1070-1078, 2017 | 53 | 2017 |
| The effect of dosing with omeprazole on the accuracy of the 13C‐urea breath test in Helicobacter pylori‐infected subjects Connor, Seow, Ngu, Katelaris Alimentary pharmacology & therapeutics 13 (10), 1287-1293, 1999 | 53 | 1999 |
| Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis R Newman, N Cuan, T Hampartzoumian, SJ Connor, AR Lloyd, ... Clinical & Experimental Immunology 139 (3), 411-420, 2005 | 52 | 2005 |
| IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Review article: consensus statements on therapeutic drug monitoring of anti … N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Aliment Pharmacol Ther 46 (11-12), 1037-53, 2017 | 50 | 2017 |
